Consistent with cultured cells, was the marked increase of DNMT3B expression—but not DNMT1 and DNMT3A—in GLO1-depleted MDA-MB-231 tumor xenografts when compared with control tumors (Fig. 2B). This evidence concerns the gene DNMT3A and neoplasm.